Introduction

Seaweeds have been used as traditional medicine and supplementary food items for centuries. At present, the commercial utilization of seaweeds is of great interest in the preparation of food products, health functional ingredients, cosmetics, and colorants (Boopathy and Kathiresan 2010). The genus Monostroma is extensively distributed throughout the world. It is predominantly consumed in Korea, Japan, China, South Australia, New Zealand, Brazil, and South America (Kavale et al. 2020). Monostroma is a marine green macroalga belonging to the family Monostromataceae and consists of a single-cell thick sheet-like thallus (monostromatic). More than 32 species have been reported (Guiry and Guiry 2022), of which: M. nitidum, M. latissimum, M. oxyspermum, M. undulatum, M. angicava, M. arcticum, and M. hariotii are identified as more nutritious and of high commercial value (FAO 2021). Among the Monostroma species, M. nitidum is mainly cultivated in Korea, accounting for 6321 t wet weight in 2019 (Lüning and Pang 2003; FAO 2021). The global green seaweed production in 2019 was 35.82 million (wet) tonnes (FAO 2021), among which the production of Monostroma and Ulva together contributed 6748 (wet) tonnes with a commercial market value of $US 54.28 million (FAO 2021).

Lahteenmaki-Uutela et al. (2020) reported that because of their delicacy and quality, Monostroma seaweeds were accepted in novel food catalogues that have been maintained online by the European Commission. This finding is similar to the reports of Gubelit et al. (2015) and Garcia-Vaquero and Hayes (2016), who reported that Monostroma has great potential to be used in food products due to the presence of substantial amounts of protein and polyunsaturated fatty acids, as compared to other seaweeds. Monostroma spp. are often used in salads, jams, soups, spices, relishes, meat, and fish dishes in Brazil, China, Japan, and the Pacific Coast of America (Kavale et al. 2020; Kaur et al. 2023). Wang and Chiang (1994) reported the processing technology of “Hai-Tsai Jam” (sea vegetable jam) and a soup of Monostroma species mixed with eggs and scallion.

Monostroma spp. contain several bioactive compounds, including polysaccharides, chlorophyll-a, chlorophyll-b, carotenoids, phenolics, flavonoids, and levoglucosan (Gordillo et al. 2006; Zhang et al. 2008; Seedevi et al. 2015; Tsubaki et al. 2016; Liu et al. 2018a; Saco et al. 2018; Song et al. 2021; Gomes et al. 2022; Kaur et al. 2023). The amount of chlorophyll-a and chlorophyll-b found in Monostroma is comparable to that found in terrestrial plants (Choudhary et al. 2021) and is responsible for their specific green colour. Among the isolated polysaccharides, rhamnan sulfate (RS) has the potential to be used commercially and has been extensively studied against various disease models, confirming the health-functional activity.

Research interest in exploring Monostroma species as viable alternatives for protein and nutrition sources is increasing. This heightened focus is attributed to the presence of essential proteins and associated health benefits, as documented by Thiviya et al. (2022). To date, a very limited number of review articles have focused on the nutritional and health-promoting effects of Monostroma spp., where the life history (Masakazu 1969; Kaur et al. 2023) and biological activities of RS extracted from M. nitidum (Suzuki and Terasawa 2020) are currently available in the database. In addition, Bast (2011) produced a book focusing on cultivation, ecophysiology, phylogeography, and molecular systematics of members of the genus. However, to the best of our knowledge there has been no systematic review of the nutritional and health-promoting bio-functional properties of Monostroma. The present review systematically updates the current research on the nutritional properties, chemical compounds, and health-beneficial effects of Monostroma spp. to encourage further commercial utilization of these seaweeds in both food and pharmaceutical industries.

Materials and methods

A systematic literature search of articles published from 2000 to the present, covering the topics of nutritional and functional properties of Monostroma species, was conducted. The articles were primarily written in English. The analysis of the literature was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Moher et al. 2009; Negara et al. 2023). Articles were searched using PubMed, ScienceDirect, Wiley Online Library, SpringerLink, and Google Scholar databases. Additionally, references in each article were further reviewed to find any relevant studies. The key search used a comprehensive list of MeSH (Medical Subject Headings) terms, including terms such as “Monostroma” and “functionality” or “compounds” or “nutrition” or “effect” or “pharmacology”. Additional search words included “antioxidant”, “antimicrobial”, “anti-hypertension”, “immunomodulation”, “seaweeds”, “seaweeds in vitro”, “seaweeds in vivo”, and “seaweeds clinical”. Original articles, conference papers, abstracts, theses, book chapters, and review articles were assessed and subjectively selected based on their relevance. Furthermore, articles were extracted and sorted using Mendeley to prevent duplicate citations (Chakniramol et al. 2022). After thorough screening, articles not fulfilling the inclusion criteria were discarded. The remaining articles were analysed and extracted, and the information included in this review.

After searching databases, a total of 130 articles were reviewed. In the final stage of screening using the PRISMA method, 72 studies were included in this review. Out of these 72 articles, 10 reported the nutritional properties, and 62 reported the health-functional properties of Monostroma.

Nutritional properties of Monostroma spp.

Many types of seaweeds are used as commercial ingredients in foods and pharmaceuticals and are considered a potential source for new food and drug development due to the presence of various macro- and micronutrients. The nutritional composition of seaweeds varies among species due to their dependence on growth conditions and environmental factors (Maehre et al. 2014; Ganesan et al. 2014; Pirian et al. 2018; Xu et al. 2023). Monostroma spp. contribute significantly to obtaining a high level of nutrition due to the abundance of dietary proteins, carbohydrates, vitamins, fibres, lipids, peptides, and mineral content (McDermid and Stuercke, 2003; Risso et al. 2003). They are used in dietary supplements due to the presence of numerous vitamins, minerals, and trace elements (Arasaki and Arasaki 1983). The proximate composition of selected Monostroma spp. is shown in Table 1.

Table 1 Proximate composition of selected Monostroma spp.

The carbohydrate content of Monostroma can range from 3.7 – 46.1% dry weight (DW; McDermid and Stuercke 2003; Risso et al. 2003; Gordillo et al. 2006; Kumar et al. 2014; Sufen et al. 2021), which is similar to that of many brown seaweeds (12.2 – 56.4% DW), as reported by Salehi et al. (2019) and Leandro et al. (2020). Among the Monostroma spp. studied, M. nitidum had the highest carbohydrate content (46.1% DW; Sufen et al. 2021), followed by M. oxyspermum (32.6% DW; McDermid and Stuercke 2003), M. undulatum (32.5% DW; Risso et al. 2003), M. arcticum (16.7% DW; Gordillo et al. 2006), and M. latissimum (8.3% DW; Kumar et al. 2014). Among the reported carbohydrates, a significant percentage is in the form of dietary fibre, which is indigestible but aids in digestion and helps control blood cholesterol. The fibre content of Monostroma species is reported to be 0.9 – 19.6% DW (Risso et al. 2003; Sufen et al. 2021), with M. undulatum having the highest fibre content of species assessed (19.6% DW; Risso et al. 2003), followed by M. nitidum (4.94% DW; Sufen et al. 2021). Chang and Wu (2008) developed seaweed noodles using M. nitidum powder, with or without eggs. They found that as the proportion of M. nitidum powder increased, there was a significant improvement in the extensibility, springiness, and breaking energy of freshly cooked noodles. Furthermore, the inclusion of seaweed powder had a noteworthy positive impact on the texture properties, cooking yield, and overall quality of the noodles, whether eggs were added or not.

Dietary fibre helps to maintain a positive environment in the gastrointestinal tract, thus providing beneficial effects on human health (Holdt and Kraan 2011; Salehi et al. 2019). Fibre also helps regulate the body’s use of sugars, helping to maintain and control blood sugars. In general, dietary fibre suppresses the increase in blood glucose levels (Yu et al. 2014; Fuller et al. 2016). The related mechanisms include: i) delay in the transfer of carbohydrates from the stomach to the duodenum and ii) inhibition of carbohydrate digestion and absorption in the small intestine. The daily demand for dietary fibre in a meal for an average human is recommended to range between 25 – 30 g (EFSA 2010). Conversely, polysaccharides consist of long chains of monosaccharides, the simple carbohydrates, linked together by glycosidic bonds (Zhu et al. 2010). Seaweeds, in general, contain 40 – 50% polysaccharides (Torres et al. 2019), which are influenced by environmental and ecological conditions. Large quantities of polysaccharides are synthesized in green seaweeds.

The cell wall of Monostroma contains a significant amount of sulfated polysaccharides (Ulvan; Lee et al. 1998; Patel 2012) with a molecular weight of approximately 10x103 to more than 1x106 Daltons (Suzuki and Terasawa 2020). Rhamnan sulphate, a sulfated polysaccharide extracted from the cell wall of M. nitidum, is the main fibre component in this species (Suzuki and Terasawa 2020). Song et al. (2021) found that rhamnan sulphate contains approximately 59 ± 9% (w/w) carbohydrate and 31 ± 4% (w/w) sulfate. It consists of a long linear chain structure of α-1,3-linked l-rhamnose connected with α-1,2-linked branched chains, to which several sulfate groups are bound (Lee et al. 2010; Tako et al. 2017). Rhamnan sulphate is the most extensively studied polysaccharide from Monostroma, probably due to its numerous nutritional and health benefits (Wang et al. 2014; Tsubaki et al. 2016; Liu et al. 2018a). Nakamura et al. (2011) reported that the extracted polysaccharides from M. nitidum had 25% sulfate groups. Sulfate groups are an important structural element responsible for macrophage-stimulating activities (Jiang et al. 2013). Activated macrophages are not only produced because of cell-mediated immune responses but they can also be produced in response to innate stimuli following viral infections or stress (Mosser and Edwards 2008). Their role in host defence against intracellular pathogens behind several autoimmune diseases, including inflammatory bowel syndrome and rheumatoid arthritis, has been well reported (Gordon and Taylor 2005; Szekanecz and Koch 2007; Dale et al. 2008; Mosser and Edwards 2008; Zhang and Mosser 2008). Other polysaccharides reported from M. nitidum are low-degree-of-polymerization (low-DP) sulfated polysaccharides, named Mon-6, Mon-24, and Mon-30 (Kazłowski et al. 2012).

The protein content of many green seaweeds is reported to be rather low compared to that of other seaweeds, but its presence with other nutrients promotes synergistic effects on animal and human health upon consumption (Leandro et al. 2020). Monostroma protein content ranges from 0.74 – 21.85% DW, where M. undulatum (Risso et al. 2003) has the highest protein content (21.85% DW), followed by M. oxyspermum (9.8% DW; McDermid and Stuercke 2003).

The lipid content of Monostroma ranges from 0.32 – 3.8% DW (McDermid and Stuercke 2003; Risso et al. 2003; Sufen et al. 2021). Seaweeds contain different polyunsaturated fatty acids (PUFAs) that essentially provide energy and help in developing the cell wall (Schmid et al. 2018). A higher lipid content has been reported in M. oxyspermum (3.9% DW; McDermid and Stuercke 2003) than in M. undulatum (1.47% DW; Risso et al. 2003), which corresponds to the increased level of PUFAs. Mohammed et al. (2021) explained that some seaweeds contain low-fat levels, thereby reducing their caloric content when ingested alone, or as a component with other food products. In addition to a relatively high lipid content, M. oxyspermum also has a higher caloric content (3300 cal g−1 ash-free DW) than other Monostroma species (McDermid and Stuercke 2003).

Monostroma undulatum had a higher ash content, varying between 33.92 and 40.05% on a dry weight basis (Risso et al. 2003), in comparison to M. oxyspermum, which had an ash content of 22.62% (McDermid and Suercke 2003). Following this, M. nitidum showed a lower ash content at 15.4% (Sufen et al. 2021). Ash contains macro- and micro-minerals or trace elements. Edible seaweeds contain most of the essential macrominerals (Ca, Mg, K, Na, and P) and microminerals (Fe, Cu, Mn, Zn, B, N, S, and I; Muñoz and Díaz 2022) required for growth and maintenance. Macrominerals are elements of essential cellular components and trace elements are natural inorganic ingredients that are required in very small quantities in the human body (<100 μg g-1); however, both macro- and micro-minerals play a vital role in the biochemical responses of living organisms (Al-fartusie and Mohssan 2017). Monostroma spp. contain different minerals and polysaccharides which improve the viscosity and overall nutritional value of other foods they are added, for example, soup and jam (Kaur et al. 2023). Due to a high amount of iodine in M. nitidum (63.6 ± 2.5 μg g-1 of dry mass; Hou et al. 1997), with an appropriate cultivation management it can be recommended as a functional food for patients with iodine deficiency. The mineral composition of selected Monostroma spp. is presented in Table 2.

Table 2 Macro- and micro-nutrients reported in selected Monostroma spp.

Among the reviewed literature, data on nitrogen (N; 2.58% DW) have only reported in M. oxyspermum (McDermid and Stuercke 2003), and data on chromium (Cr; 16.3 μg g-1), iodine (I; 63 μg g-1), nickel (Ni; 3.8 μg g-1), and aluminum (Al; 20.4 μg g-1) are only available for M. nitidum (Oza et al. 1983; Hou et al. 1997; Im et al. 2006). The World Health Organization has set a guideline value of 50 μg L-1 for the total chromium content in food (WHO 2020). Trace amounts of trivalent chromium – Cr(III) - are required for normal body functions (Bashir et al. 2021). Cr content observed in M. nitidum (16.3 μg g-1; Im et al. 2006) was higher than the one found in other food crops, including rice (2.18 ± 0.42 μg g-1), water spinach (12.80 ± 0.16 μg g-1), cabbage (0.41 ± 0.01 μg g-1), and Chinese cabbage (0.55 ± 0.01 μg g-1) (Xu et al. 2023).

With respect to macronutrients, M. undulatum contained the highest amount of phosphorus (P; 4.5% DW; Risso et al. 2003), followed by M. latissimum (0.4% DW; McDermid and Stuercke 2003). Monostroma nitidum contained the highest amount of calcium (Ca; 5.3% DW) and potassium (K; 5.28% DW), followed by M. undulatum (Risso et al. 2003). Monostroma latissimum contained the highest amount of magnesium (Mg; 1.4% DW; McDermid and Stuercke 2003) and M. undulatum contained the highest amount of sodium (Na; 13.11% DW; Risso et al. 2003). Among the micronutrients, M. latissimum contained the highest amounts of iron (Fe; 142 μg g-1), zinc (Zn; 32 μg g-1), manganese (Mn; 10 μg g-1), copper (Cu; 28 μg g-1), and boron (B; 52 μg g-1) McDermid and Stuercke (2003). Monostroma undulatum contained the highest amount of vitamin C (4.55 μg g-1) Risso et al. (2003). McDermid and Stuercke (2003) showed that M. oxyspermum powder had vitamin A (β-carotene), vitamin B3 (Niacinamide), and vitamin C in measurable amounts of 70 IU g-1, 0.70 μg g-1, and 1.3 μg g-1, respectively. Furthermore, different toxic elements such as Al, Pb, Cd, As, and Hg have been reported in some edible green seaweeds, including Caulerpa spp., Codium fragile, and Ulva clathrata (Muñoz and Díaz 2022) but, to date, not in any species of Monostroma.

The above studies showed that Monostroma spp. are a reliable source of fibre, proteins, carbohydrates, and water-soluble (B1, B2, B3, and C) and fat-soluble (β-carotene with vitamin A activity and vitamin E) vitamins, highlighting the nutritional significance of Monostroma (Skrovankova 2011).

Bioactive compounds in selected species of Monostroma

Seaweeds have great potential as nutraceuticals and pharmaceuticals due to their rich content of bioactive compounds, including secondary metabolites such as chlorophylls, polysaccharides, levoglucosan, phenolics, carotenoids, and flavonoids. The primary bioactive compounds identified in Monostroma are detailed in Table 3.

Table 3 Major bioactive components reported in selected Monostroma spp

Monostroma angicava contained sulfated polysaccharides Ls2-2 and RS (Mao et al. 2005; Liu et al. 2017, 2018a) and M. nitidum featured sulfated polysaccharide MS-1, low-DP (Mon-6 and Mon-30), RS, and levoglucosan (Luyen et al. 2006; Nakamura et al. 2011; Karnjanapratum and You 2011; Kazłowski et al. 2012; Yamashiro et al. 2017; Cao et al. 2019; Song et al. 2021). Levoglucosan, which easily hydrolyses to glucose using acid (Kitamura et al. 1991), can be utilized by various microorganisms, both eukaryotic and prokaryotic, as a carbon and energy source (Prosen et al. 1993; Nakahara et al. 1994; Zhuang et al. 2001; Khiyami et al. 2005). Monostroma latissimum contained RS, chlorophyll a, carotenoids, and flavonoids (Zhang et al. 2008; Kumar et al. 2014; Wang et al. 2014; Tsubaki et al. 2016; Saco et al. 2018). Additionally, M. oxyspermum contained sulfated polysaccharides (Seedevi et al. 2015) and M. grevillei contained polyphenols (Gomes et al. 2022).

Health-promoting effects of Monostroma spp.

Among the diverse bioactive compounds found in Monostroma, the sulfated polysaccharide called “rhamnan” holds significant importance due to its antioxidant, anti-viral, anti-thrombotic, and anti-coagulant activities (Zhang et al. 2008; Cao et al. 2019; Li et al. 2011). Arasaki and Arasaki (1983) have reported that Monostroma can combat goitre, hypertension, insomnia, stomach diseases, constipation, and digestive tract internal parasites owing to their content of vitamins, minerals, fibre, and trace elements. The following sections summarize the evidence for those bio-functionalities of selected Monostroma spp.

Antimicrobial properties

The in vitro studies have highlighted the anti-viral activity of extracts of selected Monostroma spp. against various viruses, including enterovirus 71 (EV71; Wang et al. 2018, 2020) and coronaviruses (SARS-CoV and SARS-CoV-2; Terasawa et al. 2020; Song et al. 2021). Moreover, in vivo anti-viral activity of Monostroma seaweeds has also been reported against EV71, Japanese encephalitis virus (JEV; Kazłowski et al. 2012), and influenza A virus (IFV-1; Terasawa et al. 2020). Kim and Lee (2008) reported the in vitro anti-bacterial properties of methanol extracts from M. nitidum against a broad spectrum of bacteria, including Gram-positive species such as Bacillus subtilis, Micrococcus luteus, Staphylococcus aureus, and methicillin-resistant Staphylococcus aureus CCAR and CCARM, as well as Gram-negative bacteria like Escherichia coli, Enterobacter aerogenes, Klebsiella pneumonia, Pseudomonas aeruginosa, Salmonella typhimurium, Vibrio parahaemolyticus, and Edwardsiella tarda. Lee et al. (2013) reported the bioactivity of M. nitidum ethanol and methanol extracts against Helicobacter pylori. In addition to anti-viral and anti-bacterial activities, M. nitidum methanol extracts have also shown anti-fungal activity against Candida albicans (Kim and Lee 2008). The in vitro antimicrobial activities of selected Monostroma spp. are listed in Table 4, while the in vivo studies are in Table 5, and the clinical studies are reported in Table 6.

Table 4 Antimicrobial properties of M. latissimum, M. nitidum, and M. oxyspermum – In vitro studies
Table 5 Antimicrobial properties of M. latissimum and M. nitidumIn vivo studies
Table 6 Antimicrobial properties of M. nitidum – Clinical studies

Ethanol-extracted polysaccharides from M. latissimum showed antimicrobial activity (Wang et al. 2018). An in vitro cytopathic effect (CPE) assay was performed using African green monkey kidney cells (Vero cells) infected with EV71 strain BrCr-TR and found strong cytopathic inhibition (35, 45, 65, and 85% at 0.1 μg mL-1, 1 μg mL-1, 10 μg mL-1 and 100 μg mL-1 concentration, respectively), IC50 value of 461 μg mL-1, cytotoxic concentration 50% (CC50) value of <5000 μg mL-1, and selectivity index (SI: CC50/IC50) value of >10000.0. The plaque reduction assay showed that pre-incubation of EV71 with extract at concentrations of 15.63 to 250 μg mL-1 markedly reduced the number of EV71 plaques and protected Vero cells from infection. For in vivo experiments, three-day-old neo-natal ICR mice were intra-peritoneally challenged with a 50% tissue culture infectious dose (105.5 TCID50) of EV71, followed by intra-muscular injection of extract. Five days post challenge at 5 mg kg-1, the viral titers strongly decreased in the heart (50%), brain (30%), intestine (33%), and muscle tissue (20%). The results of this study suggested polysaccharides from M. latissimum possess strong anti-EV71 activities both in vitro and in vivo with low toxicity.

Sulfated glucuronorhamnan from ethanol extracts of M. nitidum showed anti-viral activity against EV71 strain BrCr-TR (Wang et al. 2020). The IC50 values of cytopathic activity for pre-treatment of EV71 with the polysaccharide, pre-treatment of cells with the polysaccharide, and addition of the polysaccharide during and after virus adsorption were 256.91 ng mL-1, 16.11, 2.90, and 1.68 μg mL-1, respectively. The SI was above 84% during in vitro experiments. Similar to the study of Wang et al. (2018), three-day-old neo-natal ICR mice were intra-peritoneally challenged with 105.5 TCID50 of EV71 followed by an intra-muscular injection of the polysaccharide for the in vivo study. At 16 h post challenge with 10 μg mL-1, the viral titers strongly decreased in the cell supernatant (64%). The M. nitidum extracts directly inactivated EV71 virions or inhibited some stages of the virus life cycle after adsorption.

Song et al. (2021) assessed the anti-viral activity of RS from water extracts of M. nitidum against SARS-CoV-2 S-protein binding activity (RBD; related to delta variants of SARS-CoV-2; expressed in Expi293F cells). The IC50 value was 1.6 μg mL-1, and inhibition was 22 and 20% in the S-protein variants E484Q and L452R+E484Q, respectively, at 5 ng mL-1 RS. On the other hand, 1 μg mL-1 RS provided >80% viral entry inhibition (IC50) for both the wild type (2.39 μg mL-1) and delta variant (1.66 μg mL-1). Furthermore, the isolated RS demonstrated a significant ability to bind the S-protein and neutralized the pseudotyped virus in vitro. This highlights its competiveness relative to iota-carrageenan and fucoidans in their potential to combat COVID-19 (Kwon et al. 2020; Jin et al. 2020). Therefore, RS isolated from M. nitidum has the potential to be used as an anti-viral drug against coronaviruses. However, before considering the utilization of RS as a therapeutic and/or preventive anti-viral drug, it is imperative to undertake future investigations. These should encompass an exploration of the structure-activity relationship, an evaluation of bioavailability, an examination of the anti-viral activity of RS through in vivo and clinical trials, and a comprehensive toxicity analysis.

Lee et al. (2004) reported promising anti-viral activity of the sulfated polysaccharides from hot water extracts of M. nitidum against herpes simplex virus-1 (HSV-1). Vero cells for the HSV-1 and HF strains were grown in MEM supplemented with 5% FBS. The cytotoxicity of the polysaccharides was very low, with CC50, IC50, and SI values of 4100 μg mL-1, 0.4 μg mL-1, and 10000, respectively, for HSV-1 replication. Vero cells were infected with HSV-l at a high titer of 10 PFU per cell, and after 8 h of infection, the anti-HSV-1 activity value for RS was 67 μg mL-1. Therefore, RS from M. nitidum can be a potent anti-viral substance against HSV-1.

Sulfated polysaccharides from hot water extracts of M. nitidum had anti-viral activity against IFV-A and HSV-2 (Lee et al. 2010). Vero cells for the herpes simplex virus-2 (HSV-2) strain UW258 were grown in MEM supplemented with 5% FBS, and MDCK cells for the IFV-A, strains A/NWS/33 and H1N1, were grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% FBS. The polysaccharides showed low inhibitory effects, where CC50 of >10000 μg mL-1 was observed for both Vero and MDCK cells. The IC50 for HSV-1 was 0.87 μg mL-1 during infection and throughout the incubation period and 40 μg mL-1 after viral incubation. The IC50 value for IFV-A was >1000 μg mL-1 in both cases. The SI value decreased by more than 97.5% during infection and throughout the incubation period compared with that after viral incubation for HSV-2. Hence, polysaccharides from M. nitidum extracts may be useful as preventive agents for HSV-2 infection.

Rhamnan sulfate isolated from the hot water extract of M. nitidum was orally administered to IFV-infected immuno-competent (5-FU (-)) and immuno-compromised (5-FU (+)) mice, which suppressed viral proliferation (Terasawa et al. 2020). Female BALB/c mice were intra-nasally infected with 2 x 105 PFU of virus in 50 μL of phosphate-buffered saline (PBS). Oral administration of RS was performed 30 min after viral infection at a dose of 5 mg day-1 twice a day from seven days before virus inoculation to seven days after virus inoculation. Viral particles were not detected in the RS-treated 5-FU (-) mice, but the virus was still detected in the control mice and the 5-FU (+) mice after seven days of infection. Moreover, RS suppressed viral replication in both lungs at 18% and bronchoalveolar lavage fluids (BALFs) at 58% after seven days of infection compared with the control group. Not only those findings but also the CC50, EC50, and CC50/EC50 values prove that RS from M. nitidum provided anti-viral properties against enveloped viruses [HSV-1, HSV-2, human cytomegalovirus (HCMV), measles virus (MV), mumps virus (MuV), IFV-A, human immunodeficiency virus (HIV), and SARS-CoV] and non-enveloped viruses [human adenovirus type (HAV), human rhinovirus type 14 (HRV14), poliovirus type 3 (PV3), and coxsackievirus type B (CVB)].

Oral administration of RS (in a cellulose white capsule) from hot water extracts of M. nitidum showed anti-bacterial activity against bacteria such as Clostridia, Negativecutes, Acidaminococcales, and Veillonelales in a clinical study (Shimada et al. 2021). Seventy-three healthy Japanese male and female volunteers (20-65 years old) participated in this study. Each participant ingested one capsule per day for two weeks. After two weeks, Clostridia bacteria decreased in fecal matter (36.1 ± 13.0% at 0 weeks vs. 31.2 ± 12.6% at 2 weeks). This is helpful for humans because Clostridia spp. produce medium-length fatty acids that increase water absorption into cells of the gastrointestinal tract and subsequently dry up faeces, causing constipation. Rhamnan sulfate increased Negativicutes class bacteria (4.6 ± 5.0% at 0 weeks vs. 7.5 ± 5.0% at 2 weeks). In the Negativicutes, they detected four orders, and two of these orders, Acidaminococcales (1.9 ± 3.0% at 0 weeks vs. 3.2 ± 3.6% at 2 weeks) and Veillonellales (1.7 ± 2.3% at 0 weeks vs. 2.7 ± 2.5% at 2 weeks), were significantly increased by the application of RS. The increase in these bacteria is positively related to a reduction in constipation.

Kim and Lee (2008) studied the anti-fungal activity of M. nitidum methanol extracts against C. albicans; however, no significant activity was observed in this case. Hence, future research could focus on the anti-fungal activity of other Monostroma spp. The above studies indicated that Monostroma extracts and purified compounds such as RS from selected Monostroma spp. have great potential as anti-viral and anti-bacterial agents. Thus, comprehensive research studies using animal models and subsequent clinical trials are needed to further understand these properties.

Antioxidant properties

The defence mechanism of organisms against free radical attack is typically mediated by antioxidants (Arshad et al. 2014). Bioactive compounds and polysaccharides from various Monostroma spp. have shown promising antioxidant activities determined through α,α-diphenyl-β-picrylhydrazyl (DPPH) radical scavenging activity (Aguilera et al. 2002; Wu and Pan 2004; Bernardi et al. 2016), ferrous ion chelating activity, H2O2 scavenging activity (Wu and Pan 2004), enzymatic activities [superoxide dismutase (SOD) assay, glutathione reductase (GR) assay, ascorbate peroxidase (APX) assay, catalase (CAT), ascorbate; Aguilera et al. 2002; Hoang et al. 2015)], phenolic content, carotenoid content (Bernardi et al. 2016) and reducing power assay (Wu and Pan 2004). The in vitro antioxidant activities of some Monostroma spp. are listed in Table 7, and in vivo studies are presented in Table 8. To the best of our knowledge, no clinical study on the antioxidant activity of Monostroma has been reported yet.

Table 7 Antioxidant properties of selected Monostroma spp. – In vitro studies
Table 8 Antioxidant properties of M. nitidum – In vivo studies

The tripotassium phosphate extracts of M. arcticum (Aguilera et al. 2002) showed SOD, GR, APXs, CAT activity, and ascorbate content of 1004 U mg-1 TSP, 1.58 U mg-1 TSP, 0.97, U mg-1 TSP, 27.11 U mg-1 TSP, and 1.63 U mg-1 TSP, respectively. Therefore, M. arcticum extract can be used as a source of potent antioxidants of natural origin. Bernardi et al. (2016) identified antioxidants, such as phenolic compounds and carotenoids, in M. nitidum. The methanol extracts of M. nitidum showed a DPPH-radical scavenging activity of 5.1%, a phenolic content of 75.7 μg GAE g-1, and a carotenoid content of 36.3 μg g-1, suggesting potential antioxidant activity of these extracts. However, the reported concentration of these compounds in fresh vegetables, such as spinach and broccoli, is much higher than that in Monostroma spp. Spinach (Spinacia oleracea L.) hot water extracts, for instance, had a total phenolic content of 1.5 mg GAE g-1, while ethanol extracts contained 0.5 mg GAE g-1 (Ko et al. 2014). In contrast, methanol extracts of broccoli (Brassica oleracea var. Italia) have been reported to have a total phenolic content of 35.5 mg GAE g-1 (Hwang and Lim 2014). Similarly, both spinach and broccoli extracts have displayed a DPPH-radical scavenging activity exceeding 50% (Guo et al. 2001; Huang et al. 2005).

Lin et al. (2021) stated that pulsed microwave-assisted extraction of M. nitidum has antioxidant potential. A DPPH-radical scavenging activity and the ferrous ion chelating activity of 18% and 30% were measured, respectively. Hoang et al. (2015) evaluated the antioxidant activity of sulfated polysaccharides from M. nitidum. The SOD values ranged from 82 – 93% at a polysaccharide dose of 200 μg mL-1. In addition, the algal polysaccharide extract (APE) from the water extracts of M. nitidum showed 26.9% DPPH-radical scavenging activity, 75.2% ferrous ion chelating activity, 31.5% H2O2 scavenging activity, and a 10.3% reducing power effect (Wu and Pan 2004), indicating potent antioxidant activity.

The antioxidant capacity of natural products, such as compounds extracted from Monostroma spp., is attributed to the presence of polysaccharides, phenolic compounds, flavonoids, and carotenoids. These bioactive compounds are naturally occurring in both terrestrial and aquatic plants (Hayase and Kato 1984). The antioxidant activity of M. nitidum has been found to be comparable to that of the brown seaweed, Hizikia fusiformis (Lee et al. 1996). These findings highlight the robust antioxidant capacities of certain species of Monostroma, with the majority of studies conducted in vitro, except for one in vivo study (Charles et al. 2007). In addition, culture conditions and/or environment can influence antioxidant activity in seaweeds. Thus, further in vivo, and clinical studies are required to verify the antioxidant properties of the isolated substances from Monostroma spp., especially sulfated polysaccharides, since it is likely these will vary with the environmental conditions.

Anti-obesity and anti-hypercholesterolemia properties

The in vitro anti-obesity and anti-hypercholesterolemia properties of Monostroma are listed in Table 9, the in vivo studies are provided in Table 10, and the clinical studies are presented in Table 11.

Table 9 Anti-obesity activity and anti-hypercholesterolemia properties of M. angicava and M. nitidumIn vitro studies
Table 10 Anti-obesity activity and anti-hypercholesterolemia properties of M. angicava and M. nitidumIn vivo studies
Table 11 Anti-obesity activity and anti-hypercholesterolemia properties of M. latissimum and M. nitidum – Clinical studies

Hoang et al. (2015) evaluated the in vitro anti-hypolipidemic activity of sulfated polysaccharides (SPs) from ethanol extracts of M. nitidum using lipid-loaded hepatocytes (HepG2 cells). The SPs at 100 μg mL-1 markedly increased the total cholesterol (TC) and triglyceride (TG) content from 29 – 45% and from 30 – 47%, respectively. On the other hand, when the SP dose was increased to 200 μg mL-1, the TC and TG content increased from 36 – 40% and from 20 – 40%, respectively (Dir et al. 2009; Zha et al. 2012; Matloub et al. 2013). The hypercholesterolemia mechanisms induced by SPs (200 μg mL-1) in cultured hepatocytes increased the mRNA expression levels of CYP7AI and low-density lipoprotein-receptor (LDL-R) from 2.4 – 5.4 times and from 13.5 – 21.5 times, respectively.

The anti-obesity activity of RS from M. nitidum on diet-induced obese (DIO) female zebrafish, Danio rerio (AB strain), was investigated by Zang et al. (2015). Rhamnan sulphate (250 μg g-1 BW per day) administration for two weeks decreased fish body weight, plasma TG level, and plasma low-density lipoprotein-cholesterol (LDL-C) level by 11, 21.5, and 23.5%, respectively, but fasting blood glucose did not decrease. These findings indicated that RS supplementation improved dyslipidemia but not glucose intolerance. Furthermore, RS administration down-regulated the hepatic expression of cebpa, pparg, srebf1, and acacb, which are key regulators involved in the lipid synthesis pathway, indicating the purported curative properties of RS against dyslipidemia and hepatic steatosis.

Sulfated polysaccharides from hot water extracts of M. nitidum were used to treat diseases such as thrombosis and obesity (Shimada et al. 2021). Six-month-old NSY/HOS (type 2 diabetes mellitus strain) mice were fed a high-fat diet (HFD) supplemented with RS (250 mg g-1 body weight; BW) for four weeks to induce obesity. After four weeks of feeding, RS revealed a tendency to suppress body weight, plasma TG, and TC content by 7.5, 26.5, and 12%, respectively. Furthermore, RS significantly suppressed fasting blood glucose by 21.5%; however, faecal weight and calories increased by 16.67 and 16%, respectively. Thus, RS from M. nitidum has therapeutic properties capable of improving constipation issues, and thereby subsequently decreasing blood lipids and body weight.

Liu et al. (2017) studied the effect of a sulfated polysaccharide (Ls2-2) isolated from M. angicava in Sprague–Dawley (SD) rats. The in vivo glucose consumption levels were increased by 36% at 200 μg mL-1 administration of Ls2-2. The glucose consumption levels at 50 μg mL-1 and 100 μg mL-1 Ls2-2 showed a significant increase. Compared to the model group, TG levels were reduced by 30, 33, and 32% at 25, 50, and 100 μg mL-1 Ls2-2, respectively. Furthermore, the effects of Ls2-2 on glucose consumption, TG, and TC were better than those of metformin, which is used to lower blood sugar in type 2 diabetics (Maruthur et al. 2016). Therefore, M. angicava extracts could potentially be used as fibrinolytic and thrombolytic agents.

Kamimura et al. (2010) reported that oral administration of RS isolated from M. nitidum resulted in glycemic responses. For this study, Wister male rats were fed 2 g of glucose, sucrose, maltose, or soluble starch per kg BW with M. nitidum powder (200 mg kg-1 BW) or RS (approximately 50 mg kg-1 BW). The test material successfully prohibited (90%) the enhancement of plasma glucose levels after 120 min of administration compared with 30 min of administration. The effects of M. nitidum powder and RS on post-prandial enhancement in healthy human blood glucose levels were also evaluated (Kamimura et al. 2010). For the clinical trial, fifteen healthy volunteer men were selected for the oral glucose load test (OGTT). A significant decrease in the blood glucose level was found (87.5% after 120 min of administration compared with 30 min of administration). The human blood plasma level was 88 mg dL-1 after 30 min of administration and 42 mg dL-1 after 60 min of administration. Hence, RS from M. nitidum can be used as a tool to help control diabetes.

These findings indicate that certain Monostroma spp. have nutritional applications against hyperlipidemia and have beneficial anti-glycemic and anti-obesity properties.

Anti-coagulant and anti-thrombotic properties

Different sulfated polysaccharides from Monostroma species have shown effective anti-coagulants (Li et al. 2011, 2012, 2017; Liu et al. 2017, 2018b, 2018c), anti-thrombin and platelet aggregation activities. The in vitro (Table 12) and in vivo (Table 13) anti-coagulant and anti-thrombotic activities of selected Monostroma spp. have been extensively reported; however, to the best of our knowledge, these studies have not yet been proven clinically.

Table 12 Anti-coagulant and anti-thrombotic properties of selected Monostroma spp. – In vitro studies
Table 13 Anti-coagulant activity and anti-thrombotic properties of M. nitidum and M. angicavaIn vivo studies

The formation of thrombi due to enhanced platelet aggregation is known to cause artery thrombosis (Vanhoutte et al. 2009; Sprague and Khalil 2009). Sulfated polysaccharides from ethanol extracts of M. angicava showed thrombolytic activity (Li et al. 2017). The clotting time in SD rats was more than 200 s at 150 μg mL-1 in the activated partial thromboplastin time (APTT) assay and 120 s at 100 μg mL-1 in the thrombin time (TT) assay. In addition, the clot lytic rate of algal sulfated polysaccharides at 10 mg mL-1 was up to 26.49%, and at 20 mg mL-1, it was markedly higher (25%) than that in the control. This study showed that sulfated polysaccharides from M. angicava have high fibrinolytic and thrombolytic activity.

Liu et al. (2017) found that sulfated polysaccharides, Ls2-2 (molecular weight 58.4 kDa), from ethanol extracts of M. angicava have antithrombotic activity. The clotting time in SD rats was more than 200 s at 50 μg mL-1 in the APTT assay and 120 s at 200 μg mL-1 in the TT assay. In addition, the in vitro thrombolytic experiment showed that the clot lytic rate of polysaccharides increased from 24.09 - 38.11% when the dose increased from 10 to 20 mg mL-1. Later, in another study, Liu et al. (2018b) observed a 10-fold higher anti-coagulation effect of sulfated polysaccharides from M. angicava than heparin (used to treat and prevent blood clots in medical procedures). Sulfated polysaccharides in male SD rats showed a clotting time of more than 200 s at 50 μg mL-1 in the APTT assay and 120 s at 100 μg mL-1 in the TT assay. In addition, in vivo experiments showed clotting times of more than 200 s and 70 s at 16 mg kg-1 in APTT and TT assays, respectively. The clot lytic rate of seaweed polysaccharides was 38.26%. Furthermore, in a follow-up study, Liu et al. (2018c) showed sulfated polysaccharides (24 – 240 kDa) from ethanol extracts of M. angicava to have strong anti-coagulant activities evaluated through in vitro and in vivo experiments. In this case, sulfated polysaccharides in male SD rats showed a clotting time of more than 200 s at 100 μg mL-1 in vitro and 200 s at 16 mg kg-1 in vivo in the APTT assay. However, the TT assay showed a clotting time of more than 120 s at 100 μg mL-1 in vitro and a clot lytic rate of 34.29 ± 1.68% at 20 mg mL-1 in vivo. The above studies indicate that the sulfated polysaccharides of M. angicava have promising anti-coagulant properties and could effectively be used as a potential drug or food supplement for health promotion and treatment of thrombotic disease. However, a thorough investigation of the relationship between the anti-coagulant properties of these sulfated polysaccharides and their chemical structure is essential for understanding their biological characteristics. Additionally, the utilization of computational modelling techniques, such as artificial neural networks, could facilitate the identification of new polysaccharides with notable anti-coagulant activity among various Monostroma spp.

The APTT and TT assays for assessing the intrinsic coagulant activity of RS from water extracts of M. latissimum showed a clotting time of 200 s at 120 μg mL-1 in the APTT assay and 120 s at 50 μg mL-1 in the TT assay (Zhang et al. 2008). Mao et al. (2009) evaluated the anti-coagulant activity of sulfated rhamnan from the water extract of M. latissimum. The clotting time of sulfated polysaccharides (200 s and 120 s) became excessively saturated at a high concentration level of 20 μg mL-1 in the APTT assay and 10 μg mL-1 in the TT assay. Sulfated polysaccharides showed a considerable effect on the amidolytic activity of thrombin (dose increased to 100 μg mL-1 and thrombin activity decreased to 7%) in the presence of heparin cofactor II, which was strong like heparin. Sulfated polysaccharides also had a considerable effect on the amidolytic activity of thrombin (dose increased to 103 μg mL-1, resulting in a 20% decreased activity) when combined with anti-thrombin III. Li et al. (2011) reported that low molecular weight (513 kDa) active polysaccharides from M. latissimum hot water extracts showed clotting times exceeding 200 s at 150 μg mL-1 in the APTT assay and over 120 s at 100 μg mL-1 in the TT assay.

In a follow-up study, Li et al. (2012) reported that a low molecular weight polysaccharide (3.4 kDa) derived from M. latissimum had strong anti-coagulant properties. Inhibition of thrombin activity by this polysaccharide was examined by amidolytic anti-factor thrombin and coagulation factor Xa assays in the absence and presence of heparin cofactor II (70 nmol L-1) and anti-thrombin III (50 nmol L-1). APTT activity by the polysaccharides slowly increased, and the clotting time was more than 200 s at 50 μg mL-1. The polysaccharides had a considerable effect on the amidolytic activity of thrombin (dose increased to 1 μg mL-1 and thrombin activity decreased to 5%). The polysaccharides weakly inhibited the amidolytic activity of thrombin in a dose-dependent manner when heparin cofactor II or anti-thrombin was absent. However, polysaccharides exhibited a considerable effect on thrombin inhibition through a heparin cofactor II-dependent pathway, and the ability to inhibit thrombin was stronger (dose increased to 1 μg mL-1 and thrombin activity decreased to 42%) than that of heparin. The above studies highlight that the sulfated polysaccharide of M. latissimum can be a potent anti-coagulant agent and promising thrombin inhibitor mediated by heparin cofactor II. However, this requires further detailed investigation as candidates for use in food supplements or ingredients in the pharmaceutical industry.

Sulfated rhamnan from water extracts of M. nitidum showed excessively saturated (200 s and 120 s) clotting times at high concentrations of 15 μg mL-1 in the APTT assay and 50 μg mL-1 in the TT assay (Mao et al. 2008). The polysaccharides had a considerable effect on the amidolytic activity of thrombin (dose increased to 1 μg mL-1 and thrombin activity decreased to 7%) in the presence of heparin cofactor II. The polysaccharides weakly inhibited the amidolytic activity of thrombin in a dose-dependent manner when heparin cofactor II or anti-thrombin was absent. The polysaccharides had a considerable effect on the amidolytic activity of thrombin (dose increase to 1 μg mL-1 and thrombin activity decrease to 30 - 38%) in the presence of anti-thrombin III.

The RS from water extracts of commercially cultured M. nitidum showed potential anti-coagulant activity (Yamashiro et al. 2017). The relative activity of RS (75 μg mL-1 and 150 μg mL-1) in the APTT, TT and PT assays, ranged from 60 - 78%, 138 - 170%, and 120 - 123%, respectively, and was comparable to that of heparin (100%). Hence, the RS from M. nitidum may prolong the extrinsic and common pathways of coagulation by inhibiting thrombin activity. In another study by Okamoto et al. (2019), RS (100 μg mL-1) from hot water extracts of M. nitidum significantly suppressed tissue factor (TF) expression (5%) and von Willebrand factor (VWF) release (50%) compared with heparin. Tumor necrosis factor (TNF)-α (a major pro-inflammatory cytokine) and thrombin (coagulation factor) significantly induced the expression of RS (100 μg mL-1) by TF activity (0% and 50%) and VWF release (45% and 80%) in activated endothelial cells. The sulfated polysaccharide in the above studies showed potent anti-coagulant and thrombin inhibiting activities mediated by heparin cofactor II, suggesting that some Monostroma species can be effective in helping to prevent the development of venous thrombosis.

Anti-inflammatory properties

The in vitro and in vivo anti-inflammatory activities of selected extracts of Monostroma spp. are presented in Tables 14 and 15, respectively; however, to the best of our knowledge, these studies have not yet been proven clinically.

Table 14 Anti-inflammatory properties of M. nitidumIn vitro studies
Table 15 Anti-inflammatory properties of M. nitidumIn vivo studies

Crude RS from M. nitidum extracts prevents endothelial inflammation and regulates the onset of thrombotic disorders (Okamoto et al. 2019). The isolated RS strongly decreased TF expression (from 100% to near zero at doses above 3 μg mL-1) and slightly suppressed TNF-α-induced VWF release (decreasing from 100 to 50% with increasing RS concentration). Hence, RS from M. nitidum may be a potential candidate for food supplementation possessing anti-thrombotic and anti-inflammatory effects. However, additional research at in vivo and clinical stages is necessary before incorporating these extracts into food applications.

The ethanol extracts of M. nitidum showed promising anti-inflammatory activity (Hoang et al. 2015). In lipid-loaded hepatocytes, the mRNA expression of iNOS, interleukin (IL)-6, and IL-8 decreased by 79.5, 63.6, and 66.7%, respectively, at a 200 μg mL-1 dose of sulfated polysaccharides. Furthermore, at dosage of 20 μM, a 33% reduction in visfatin, a pro-inflammatory gene expression, was noted. Therefore, it is likely that the lipid-lowering effect of the sulphated polysaccharides can be achieved by reducing elevated levels of pro-inflammatory mediators and visfatin mRNA expression. This suggests that sulfated polysaccharides from M. nitidum may assist in reducing the elevated expression of pro-inflammatory molecules, such as iNOS, IL-6, IL-8, and visfatin.

Overall, RS and other sulfated polysaccharides from various Monostroma species have shown strong attenuation of inflammatory injury in cultured vascular endothelial cells suggesting that polysaccharides extracted from Monostroma spp. could be a potential anti-inflammatory agent for cellular inflammation. Future in vitro, in vivo and clinical research is needed to verify their pharmacological properties.

Immunomodulatory properties

The in vitro and in vivo immunomodulatory properties of selected Monostroma spp. are presented in Tables 16 and 17, respectively; however, to the best of our knowledge, these studies have not yet been proven clinically.

Table 16 Immunomodulatory properties of M. nitidum and M. oxyspermumIn vitro studies
Table 17 Immunomodulatory properties of M. angicava and M. nitidumIn vivo studies

Sulfated polysaccharides from ethanol extracts of M. nitidum have shown promising anti-cancer and immunomodulatory activities (Karnjanapratum and You 2011). The immunomodulatory effects of crude sulfated polysaccharides were determined by measuring the proliferation rate of Raw 264.7 cells. The cytotoxic effect of the crude polysaccharides at a concentration of 6.25 μg mL-1, as measured by Raw 264.7 cell proliferation, was considerably improved and exhibited a significant potency to induce nitric oxide (NO; > 40 μM) and prostaglandin E2 (PGE2) production (> 11 ng mL-1) compared with lipopolysaccharide (LPS; 42 μM and 12 ng mL-1). A human gastric carcinoma cell line (AGS cells) and a human cervical cancer cell line (HeLa cells) were used in the colorimetric assay to determine the anti-cancer activity. Growth inhibition of AGS and HeLa cells was found at 80% and 64% in 125 μg mL-1 of crude sulfated polysaccharide. These findings suggest that crude polysaccharides from M. nitidum could function as anti-cancer and immunomodulatory agents.

Chen et al. (2021) studied the anti-fatigue activity of sulfated polysaccharides from M. nitidum using a senescence-accelerated male mouse prone-8 (SAMP8) animal model. Polysaccharides from hot water extracts of M. nitidum were supplemented with a mixture of fermented Tilapia by-products and provided to mice. Blood samples were collected 30 min after the last feed. Blood was collected after 20 min during the post swimming rest period (10 min at 30°C temperature water). The blood urea nitrogen (BUN) concentration of the training group was significantly lower (25 mg dL-1) than that of the non-training group (30 mg dL-1). The lactate concentrations were 20.4%, 25.2%, and 25.7% in the mixed-dose groups of 412, 824, and 1648 mg kg-1 BW per day, respectively. The results showed that 824 mg kg-1 BW per day and 1648 mg kg-1 BW per day doses of the mixture with exercise training (ET) could significantly increase the liver glycogen level (10 to 11 mg g-1) compared with the non-training group (7 mg g-1 liver).

Present and future prospects for applied research using various Monostroma spp.

Monostroma spp. have been included in the Novel Food Catalogue of the European Commission as macroalgal species owing to their delicacy and quality (Lahteenmaki-Uutela et al. 2020). Research on the nutritional and functional activities of Monostroma spp. is progressively increasing. Monostroma spp. contain carbohydrates, fibre, polysaccharides, protein, and minerals, making them suitable for use as a valuable food supplement. However, nutritional properties of various species of Monostroma are influenced by environmental and ecological conditions (Torres et al. 2019); thus, the nutritional properties of Monostroma species from different countries may vary significantly. It is worth noting that even the same species can exhibit substantial differences in its metabolic profile when found in distinct geographical location. Furthermore, the nutritional properties of only a limited number of Monostroma species have been explored. Therefore, unexplored Monostroma species, such as M. angicava, and M. grevillei should be considered for future study, and their nutritional properties should be explored.

Some of the Monostroma species have exhibited significant bio-functional activities, including anti-viral, antimicrobial, anti-inflammatory, anti-glycemic, anti-obesity, anti-thrombotic, anti-coagulant, antioxidant, anti-cancer, anti-fatigue, and immunomodulatory activities (Zhang et al. 2008; Kamimura et al. 2010; Karnjanapratum and You 2011; Hoang et al. 2015; Zang et al. 2015; Cao et al. 2019; Okamoto et al. 2019; Terasawa et al. 2020; Chen et al. 2021; Shimada et al. 2021). However, despite the use of novel and precise analytical techniques such as GC-MS, LC-MS, HRMS, and updated databases to explore new compounds in seaweeds, including edible algae (Vaghela et al. 2022, 2023), only a limited number of articles have addressed the phytochemical characterization of Monostroma species. Therefore, there is a need to focus on the intense phytochemical characterization of Monostroma spp. in future research.

The anti-viral activity against different enveloped (SARS-CoV, HIV, HSV, HCMV, MV, MuV, IFV, and HIV) and non-enveloped (EV71, HAV, PV, CVB, and HRV) viruses has been addressed by in vitro studies of M. latissimum and M. nitidum (Lee et al. 2004, 2010; Kazłowski et al. 2012; Wang et al. 2018, 2020; Terasawa et al. 2020; Song et al. 2021). The IC50, CC50, EC50, NA inhibition assay, and plaque assay results were mainly considered to determine the anti-viral activity (Lee et al. 2004; Wang et al. 2018; Terasawa et al. 2020; Wang et al. 2020). However, virus-binding (attachment) assays and penetration assays have not been conducted, which could be considered in future studies.

Anti-obesity and anti-hypercholesterolemia activities of M. angicava and M. nitidum were extensively addressed by in vitro, in vivo, and clinical studies (Kamimura et al. 2010; Ko et al. 2011; Cancel and Tarbell 2013; Hoang et al. 2015; Zang et al. 2015; Liu et al. 2017; Shimada et al. 2021; Patil et al. 2022). A total of 14 articles reported the anti-coagulant and anti-thrombotic effects of selected Monostroma spp. Remarkable results were noted in vitro and in vivo settings, sometimes approximately 10-fold higher than those of conventional medicine (Liu et al. 2018b). However, only a limited number of studies have reported anti-bacterial (Kim and Lee 2008; Lee et al. 2013; Shimada et al. 2021), anti-fungal (Kim and Lee 2008), and antioxidant properties of selected Monostroma species.

One study reported the anti-cancer and immunomodulatory activity of M. nitidum with remarkable inhibition in AGS and HeLa cells (Karnjanapratum and You 2011). However, it remains unconfirmed whether this anti-cancer activity results from the cytotoxic effect. Future studies on the anti-cancer activities of Monostroma can be extended with various cancer cell lines, elucidating the molecular mechanisms underlying their preventive effects in culture conditions. Rhamnan sulfate and other sulfated polysaccharides from M. nitidum attenuate inflammatory injury in vascular endothelial cells in vitro (Hoang et al. 2015). This provides a comprehensive research scope at in vivo and clinical levels to identify the potential anti-inflammatory compounds from Monostroma species.

While numerous bioactivities have been assessed through in vitro studies, there is a considerable scope for further research involving animal models and subsequent clinical trials. Addressing this gap is crucial to elucidate the potential bioactivities of the studied Monostroma spp., facilitating translational research. This, in turn, could open avenues for utilizing these species in food supplements and medicinal applications.

Conclusion

This study highlights that amongst the various species of Monostroma, M. nitidum is the most extensively studied species, offering a valuable source of substances with extensive nutritional and functional properties. Monostroma species have been utilized both as ingredient in traditional medicines and as a source of dietary substances. Many bioactive compounds, including polysaccharides (such as ‘RS’ and low molecular weight polysaccharides), phenolics, flavonoids, chlorophyll, levoglucosan, and carotenoids, have been extracted from several Monostroma spp. and harnessed for their use in both food and medicine. The nutritional and functional attributes of some Monostroma spp. underscores their potential for commercial application. However, ensuring the sustainable management of oceanic resources presents challenges concerning the preservation of nutritional quality and bioactive components. This knowledge forms the basis for the development of functional ingredients for pharmaceuticals and functional foods. This review involved an analysis of previous studies focusing on the nutritional properties and activities of Monostroma seaweeds, thereby providing valuable insights and guidelines for future research aimed at expanding the application of some Monostroma spp. It is worth noting that while studies have explored the properties of some Monostroma spp. in vitro, only a limited number of investigations have conducted in vivo and clinical trials. Therefore, further research in in vivo and clinical settings should be pursued to fully understand their bioactivities. Furthermore, conducting a thorough toxicity analysis of the isolated compounds would contribute to the enhanced utilization of extracts from Monostroma spp. in food applications.